Rimonabant
From Buy Rimonabant, Acomplia Weight Loss Pills
Contents |
Rimonabant - What should I know about Rimonabant (Acomplia) Treatment?
What is Rimonabant (Acomplia)?
|
Rimonabant (also known as SR141716, Acomplia, Riobant, Slimona, Rimoslim, and Zimulti) is an anorectic anti-obesity drug. It is an inverse agonist for the cannabinoid receptor CB1. Its main avenue of effect is reduction in appetite. Under development by Sanofi-Aventis, Acomplia (rimonabant) is a selective CB1 endocannabinoid receptor antagonist indicated for the treatment of obesity. Buy Rimonabant (Acomplia) producted only by known company. Rimonabant online is a miracle drug, which is helpful in weight loss as well as helpful in maintain weight. For obese or overweight patients, buy rimonabant in uk is the best drug for them to lose weight. Clinical trials show that 33% of obese patient who take rimonabant lose 10% of weight. Buy Rimonabant to get promising results over weight loss.
As Rimonabant (Acomplia) is called the "miracle pill", how it works?
Rimonabant works by blocking endogenous cannabinoid binding to neuronal CB1 receptors. Activation of these receptors by endoegenous cannabinoids, such as anadamide, increases appetite. Rimonabant Acomplia is the first of a new class of drugs that block the cannabinoid receptor 1 (CB1). The CB1 receptor is thought to play an important role in certain aspects of human behavior and metabolism - specifically, it is thought to play a role in obesity and lipid glucose metabolism. Rimonabant is the most advanced endocannabinoid receptor antagonist in clinical development and offers a novel therapeutic approach to appetite control and weight reduction. You may buy Rimonabant, it also has potential as a treatment for smoking cessation because the endocannabinoid system is involved in the body's response to tobacco dependence. Buy Rimonabant acomplia, a lead cannabinoid antagonist works by blocking the cannabinoid receptors. This receptor is also present in the fat tissue and controls the hunger in the brain. Rimonabant acomplia online blocks this receptor and hence people do not feel hunger. The main property of rimonabant acomplia is that it blocks the cannabinoid receptor.
Can I buy Rimonabant (Acomplia), is it safe to use?
Rimonabant (Acomplia) has been available to buy in Europe since the middle of 2006, following regulatory approval by the EMEA in June 2006 for its use as an adjunct to diet and exercise for obese or overweight patients with associated risk factors, such as type 2 diabetes or dyslipidaeamia. The French pharma firm Sanofi-Aventis disclosed that a complete response to the FDA's approvable letter was submitted on October 26, 2006, triggering a Class I (two-month) or Class II (six-month) review process in USA. On 21 June 2006, the European Commission approved the sale of rimonabant in the then 25-member European Union, you are welcomed to buy Rimonabant and start the Acomplia treatment. Sanofi announced that the first country in which Rimoanabant (Acomplia) will be sold is the United Kingdom. Sales began in July 2006. Sanofi also announced that it projects that Rimoanabant will be sold shortly thereafter in Denmark, Ireland, Germany, Finland and Norway. It is expected in Belgium and Sweden in 2007. Ordinary obesity will, according to official medical recommendations.
What are the other uses of Rimonabant (Acomplia)?
Tetrahydrocannabinol is known to impair short-term memory. It was therefore hypothesised that Rimonabant may improve short-term memory. Indeed in animal studies it significantly improved the performance of rats to encode information in the short-term memory. Buy Rimonabant online as it can also help you improve short-term memory. Rimonabant may also be found to be effective in assisting some smokers to quit smoking. Sanofi-Aventis is currently conducting studies to determine the possible value of rimonabant in smoking-cessation therapy. The Studies with Rimonabant and Tobacco Use (STRATUS) Program involves more than 6,000 subjects. STRATUS is designed to explore two smoking-related therapies: first, to use rimonabant directly to aid in smoking cessation; second, to help prevent weight gain in former smokers. Initial results apparently suggest that rimonabant is effective for both uses, and advise to buy rimonabant and start the treatment. Rimonabant (acomplia) reduced resumption of cocaine-seeking responses triggered by two of the three most common triggers of relapse in humans, priming and cues.
- Rimonabant - Acomplia: 5-(4-Chlorophenyl)-1-(2,4-dichloro-phenyl)- 4-methyl-N-(piperidin-1-yl)- 1H-pyrazole-3-carboxamide
